摘要
Aberrant N6-methyladenosine (m6A) modification on mRNA is correlated with cancer progression. However, the role of m6A on ribosomal RNA (rRNA) in cancer remains poorly understood. Our current study reveals that METTL5/TRMT112 and their mediated m6A modification at the 18S rRNA 1832 site (m6A1832) are elevated in nasopharyngeal carcinoma (NPC) and promote oncogenic transformation in vitro and in vivo. Moreover, loss of catalytic activity of METTL5 abolishes its oncogenic functions. Mechanistically, m6A1832 18S rRNA modification facilitates the assembly of 80S ribosome via bridging the RPL24-18S rRNA interaction, therefore promoting the translation of mRNAs with 50 terminal oligopyrimidine (50 TOP) motifs. Further mechanistic anal-ysis reveals that METTL5 enhances HSF4b translation to activate the transcription of HSP90B1, which binds with oncogenic mutant p53 (mutp53) protein and prevents it from undergoing ubiquitination-dependent degradation, therefore facilitating NPC tumorigenesis and chemoresistance. Overall, our findings uncover an innovative mechanism underlying rRNA epigenetic modification in regulating mRNA translation and the mutp53 pathway in cancer.
学科与关键词
- The roles of N6-methyladenosine and its target regulatory noncoding RNAs in tumors: classification, mechanisms, and potential therapeutic implicationsLiu, Ziying; Gao, Lei; Cheng, Long; Lv, Gaoyuan; Sun, Bei; Wang, Gang*; Tang, Qiushi*Experimental and Molecular Medicine, 2023, 55(3): 487-501.被引 5
- METTL3 Intensifies the Progress of Oral Squamous Cell Carcinoma via Modulating the m6A Amount of PRMT5 and PD-L1Ai, Yilong; Liu, Shiwei; Luo, Hailing; Wu, Siyuan; Wei, Haigang; Tang, Zhe; Li, Xia; Lv, Xiaozhi*; Zou, ChenJournal of Immunology Research, 2021, 2021: 6149558.被引 24
- N6-methyladenosine regulates glycolysis of cancer cells through PDK4Zihan, Li; Yanxi, Peng; Jiexin, Li; Zhuojia, Chen; Feng, Chen; Jian, Tu; Shuibin, Lin; Hongsheng, WangNature Communications, 2020, 11(1): 2578.被引 29
